[Use of biseptol for preventing the development of rifampicin-resistant Mycobacterium tuberculosis].
D003470:Culture Media; D004338:Drug Combinations / Q000494:pharmacology; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D012293:Rifampin / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D013420:Sulfamethoxazole / Q000494:pharmacology*; D014295:Trimethoprim / Q000494:pharmacology*; D014296:Trimethoprim Resistance; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D003470:Culture Media; D004338:Drug Combinations; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole; D012293:Rifampin
Ispol'zovanie biseptola s tsel'iu predotvrashcheniia razvitiia rifampitsinoustoĭchivosti mikobakteriĭ tuberkuleza.